56
Participants
Start Date
March 31, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
paroxetine 10mg tablet
1 or 2 tablet(s) once a day
paroxetine 20mg tablet
1 tablet once a day
matched placebo to paroxetine 10mg
2 tablets once a day
matched placebo to paroxetine 20mg
1 tablet once a day
GSK Investigational Site, Aichi
GSK Investigational Site, Aichi
GSK Investigational Site, Aichi
GSK Investigational Site, Aichi
GSK Investigational Site, Fukui
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hyōgo
GSK Investigational Site, Hyōgo
GSK Investigational Site, Hyōgo
GSK Investigational Site, Ishikawa
GSK Investigational Site, Kagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kumamoto
GSK Investigational Site, Kumamoto
GSK Investigational Site, Kumamoto
GSK Investigational Site, Nagano
GSK Investigational Site, Nara
GSK Investigational Site, Nara
GSK Investigational Site, Okayama
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Shizuoka
GSK Investigational Site, Tokushima
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
Lead Sponsor
GlaxoSmithKline
INDUSTRY